CinCor Pharma Inc. (CINC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

CinCor Pharma Inc.

NASDAQ: CINC · Real-Time Price · USD
29.06
0.00 (0.00%)
At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-88.09M -76.14M -61.45M -50.37M -26.83M -17.81M -11.43M
Depreciation & Amortization
4.21K n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
4.52M 3.66M 2.83M 3M 2.25M 1.8M 1.39M
Other Working Capital
6.07M -530.6K -4.84M 2.24M -5.48M -3.45M -1.83M
Other Non-Cash Items
16.25M 17.84M 19.19M 17.39M 4.06M 2.72M 1.51M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
3.92M 106.19K -3.36M -871.15K -4.37M -5.37M -2.32M
Operating Cash Flow
-63.41M -54.53M -42.79M -30.85M -24.9M -18.66M -10.85M
Capital Expenditures
-63.2K n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-335.39M -227.23M -159.84M n/a n/a n/a n/a
Sales Maturities Of Investments
105M 60M 10M n/a n/a n/a n/a
Other Investing Acitivies
-42.14K -42.14K n/a n/a n/a n/a n/a
Investing Cash Flow
-230.5M -167.27M -149.84M n/a n/a n/a n/a
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
444.75M 335.69M 336.92M 141.37M 135.45M 1.23M 5.00
Financial Cash Flow
444.75M 335.69M 336.92M 141.37M 135.45M 1.23M 5.00
Net Cash Flow
150.85M 113.89M 144.3M 110.53M 110.55M -17.43M -10.85M
Free Cash Flow
-63.47M -54.53M -42.79M -30.85M -24.9M -18.66M -10.85M